Drug Shortage Report for TEVA-CLOXACILLIN
Report ID | 198587 |
Drug Identification Number | 00337773 |
Brand name | TEVA-CLOXACILLIN |
Common or Proper name | TEVA-CLOXACILLIN |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CLOXACILLIN |
Strength(s) | 500MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | J01CF |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-07-13 |
Estimated end date | 2023-08-20 |
Actual end date | 2023-08-30 |
Shortage status | Resolved |
Updated date | 2023-10-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2023-10-03 | French | Compare |
v8 | 2023-10-03 | English | Compare |
v7 | 2023-08-18 | French | Compare |
v6 | 2023-08-18 | English | Compare |
v5 | 2023-08-17 | French | Compare |
v4 | 2023-08-17 | English | Compare |
v3 | 2023-07-14 | English | Compare |
v2 | 2023-07-13 | French | Compare |
v1 | 2023-07-13 | English | Compare |
Showing 1 to 9 of 9